Roche CEO: Illumina offer 'fair'; Boston Sci eyes acquisitions;

@FierceMedDev: How to be a good medical device sales rep today (Best of MedCitizens)--MedCity News. Article | Follow @FierceMedDev

> Roche ($RHHBY) is willing to pay up to $5.7 billion on a potential hostile takeover of Illumina ($ILMN) to get into the gene-sequencing market, CEO Severin Schwan (photo) has said. "We looked at the competitive landscape when we made this offer and feel it is a compelling offer that is a full and fair price," he told CNBC last week. Story

> Boston Scientific ($BSX) is planning to reserve most of the $1 billion in free cash it expects to generate this year for acquisitions, with plans to use 25% to buy back shares, CFO Jeff Capello said last week. News

> The Pittsburgh Life Sciences Greenhouse has finished raising $8.1 million, but two-thirds of that total has been invested or reserved. News

> The IRS has issued proposed regulations covering the excise taxes imposed on the sale of medical devices under the healthcare reform law. Report

> VeriTeQ will offer its FDA-cleared VeriChip microchip for the identification of breast implants and other medical devices. VeriTeQ release

And Finally... GE is investing in Israel's Check-Cap, which is developing swallowable endoscopic capsules for imaging the insides of the GI tract. The company's offering could compete with Given Imaging's ($GIVN) PillCams. Story

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.